Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules

Annals of Thoracic Surgery

Volumn 66, Issue 6, 1998, Pages 2135-2144

  Asimakopoulos, George ^a   Taylor, Kenneth M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOPULMONARY BYPASS; CELL ADHESION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOPULMONARY BYPASS; CELL ADHESION MOLECULES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032451449     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00727-9     Document Type: Review

References (89)

1. 1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-8.
2. 2. Hannan EL, Kilburn H, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass graft surgery in New York State. JAMA 1994;271:761-6.
3. 3. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
4. 4. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leucocyt Biol 1994;55:662-75.
5. 5. Wakefield CH, Carey PD, Foulds S, Monson JRT, Guillou PJ. Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response. Arch Surg 1993;128:390-5.
6. 6. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
7. 7. Nomoto S, Shimahara Y, Kumada K, Okamoto Y, Ban T. Influence of hepatic mitochondrial redox state on complement biosynthesis and activation during and after cardiopulmonary bypass operations. Eur J Cardiothorac Surg 1996; 10:273-8.
8. 8. Chenoweth DE, Hugli TE. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 1978;75:3943-7.
9. 9. Salama A, Hugo F, Heinrich D, et al. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Engl J Med 1988; 318:408-14.
10. 10. Rinder CS, Rinder HM, Smith BR, et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 1995;96: 1564-72.
11. 11. Wachtfogel YT, Pixley RA, Kucich U, et al. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 1986;67:1731-7.
12. 12. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effects of cardiopulomonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
13. 13. Quiroga MM, Miyagishima R, Haendschen LC, Glovsky M, Martin BA, Hogg JC. The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;90:91-6.
14. 14. Steinberg BM, Grossi EA, Schwartz DS, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995;60:525-9.
15. 15. Weerwind PW, Maessen JG, van Tits LJH, et al. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 1995;110:1633-41.
16. 16. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:625-5.
17. 17. Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G. Serum levels of 1L-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992;89:255-60.
18. 18. Menasché P, Haydar S, Peynet J, et al. A potential mechanism of vasodilatation after warm heart surgery: the temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994;107:293-9.
19. 19. Jansen NJG, van Oeveren W, v.d. Broek L, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:515-25.
20. 20. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulomonary bypass. Ann Thorac Surg 1995;60:801-4.
21. 21. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53:833-8.
22. 22. Sawa Y, Shimazaki Y, Kadoba K, et al. Attenuation of cardiopulmonary by pass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 1996;111:29-35.
23. 23. Inaba H, Kochi A, Yorozu S. Suppression by methylprednisolone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass. Br J Anaesth 1994;72348-50.
24. 24. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993;40:1016-21.
25. 25. Taylor KM. SIRS - The Systemic Inflammatory Response Syndrome after cardiac operations. Ann Thorac Surg 1996; 61:1607-8.
26. 26. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-12.
27. 27. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemic-reperfusion. Cardiovasc Res 1996;32:743-51.
28. 28. Bevilaqua MP, Nelson RM. Selectins. J Clin Invest 1993;91: 379-87.
29. 29. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995;75:724-33.
30. 30. Galinanes M, Watson C, Trivedi U, Chambers DJ, Young CP, Venn GE. Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation 1996;94(suppl 2):364-9.
31. 31. Le Deist F, Menasché P, Bel A, Lariviere J, Piwnica A, Bloch G. Patterns of changes in neutrophil adhesion molecules during normothermic cardiopulmonary bypass. A clinical study. Eur J Cardiothorac Surg 1996;10:279-83.
32. 32. Le Deist F, Menasché P, Kucharski C, Bel A, Piwnica A, Bloch G. Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion. A clinical study. Circulation 1995;92(Suppl 2):354-8.
33. 33. Dreyer WJ, Michael LH, Millman EE, Berens KL. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovascular Research 1995;29:775-81.
34. 34. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:105-11.
35. 35. Hogevold HE, Moen O, Fosse E, et al. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Perfusion 1997;12:9-20.
36. 36. Finn A, Morgan BP, Rebuck N, et al. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:451-9.
37. 37. Thurlow PJ, Doolan L, Sharp R, Sullivan M, Smith B. Studies of the effect of Pall leucocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system. Perfusion 1995;10:291-300.
38. 38. El Habbal MH, Carter H, Smith LJ, Elliott MJ, Strobel H. Neutrophil activation in paediatric extracorporeal circuits: effect of circulation and temperature variation. Cardiovascular Research 1995;29:102-7.
39. 39. Van Eeden S, Miyagashima R, Haley L, Hogg JC. L-selectin expression increases on peripheral blood polymorphonuclear leukocytes during active marrow release. Am J Respir Crit Care Med 1995;151:500-7.
40. 40. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880-6.
41. 41. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989;73:1109-12.
42. 42. Larsen E, Celi A, Gilberty GE, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-12.
43. 43. Geng J-G, Bevilaqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-60.
44. 44. Weller A, Isenmann S, Vestweber D. Cloning of the mouse endothelial selectins. Expression of both E-and P-selectin is inducible by tumor necrosis factor. J Biol Chem 1992;267: 15176-83.
45. 45. Kadletz M, Dignan RJ, Loesser KE, Hess ML, Wechsler AS. Ischaemia and activated neutrophils alter coronary microvascular but not epicardial coronary artery reactivity. J Thorac Cardiovasc Surg 1994;108:648-57.
46. 46. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
47. 47. Miura T, Nelson DP, Schermerhorn ML, et al. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts. Ann Thorac Surg 1996;62:1295-300.
48. 48. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
49. 49. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. 1993;82:107-17.
50. 50. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass blood. J Thorac Cardiovasc Surg 1994;107:280-8.
51. 51. Menasché P, Peynet J, Haeffner-Cavaillon N, et al. Influence of temperature on neutrophil trafficing during clinical cardiopulmonary bypass. Circulation 1995;92(suppl 2):334-40.
52. 52. Komai H, Haworth SG, Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg 1994;58:478-82.
53. 53. Mathew JP, Rinder CS, Tracey JB, et al. Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;109: 448-56.
54. 54. Wahba A, Black G, Koksch M, et al. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thrombosis Haemostasis 1996;75:844-8.
55. 55. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-33.
56. 56. Mason JC, Haskard DO. The clinical importance of leukocyte and endothelial cell adhesion molecules in inflammation. Vascular Med Rev 1994;5:249-75.
57. 57. Boldt J, Osmer C, Linke LC, Dapper F, Hempelmann G. Circulating adhesion molecules in pediatric cardiac surgery. Anesth Analg 1995;81:1129-35.
58. 58. Boldt J, Osmer C, Schindler E, Linke L-Ch, Stertmann W-A, Hempelmann G. Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin. Ann Thorac Surg 1995;59:100-5.
59. 59. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1714-20.
60. 60. Kilbridge PM, Mayer JE, Newburger JW, Hickey PR, Walsh AZ, Neufeld EJ. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:1183-92.
61. 61. Stewart M, Thiel M, Hogg N. Leukocyte integrins. Curr Opin Cell Biol 1995;7:690-6.
62. 62. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76: 301-14.
63. 63. Plow EF, Zhang L. A MAC-1 attack: integrin functions directly challenged in knockout mice. J Clin Invest 1997;99: 1145-6.
64. 64. Lu H, Smith CW, Perrard J, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest 1997;99:1340-50.
65. 65. Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 1993;120:545-56.
66. 66. Gillinov AM, Bator JM, Zehr KJ, et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 1993; 56:847-53.
67. 67. Gillinov AM, Redmond JM, Winkelstein JA, et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 1994;57:345-52.
68. 68. Zehr KJ, Poston RS, Lee PC, et al. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 1995;59:328-35.
69. 69. Gillinov AM, Redmond JM, Zehr KJ, et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 1994;57:126-33.
70. 70. Redmond JM, Gillinov AM, Stuart S, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993;56:474-9.
71. 71. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997;576-84.
72. 72. Hill GE, Alonso A, Thiele GM, Robbins RA. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg 1994;79:23-7.
73. 73. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
74. 74. Takala AJ, Jousela IT, Takkunen OS, et al. Time course of β2-integrin CD11b/CD18 (Mac-1, αMβ2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. Scand J Thor Cardiovasc Surg 1996;30:141-8.
75. 75. Kappelmeyer J, Bernabei A, Gikakis N, Edmunds LH Jr, Colman RW. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J Lab Clin Med 1993;121:118-26.
76. 76. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995;110:1658-62.
77. 77. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Ann Rev Immunol 1990;8:365-400.
78. 78. Bevilaqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Ann Rev Med 1994;45:361-78.
79. 79. Wayner EA, Garcia-Pardo A, Humphries MJ, MacDonald JA, Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989; 109:1321-30.
80. 80. Coito AJ, Binder J, Brown LF, de Sousa M, van de Water L, Kupiec-Weglinski JW. Anti-TNF-α treatment down-regulated the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats. J Immunol 1995; 154:2949-58.
81. 81. Menasché P, Peynet J, Lariviere J, et al. Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? Circulation 1994;90(part 2):275-9.
82. 82. Hwang S-J, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 1997;96:4219-25.
83. 83. Ridker PM, Hennekers CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
84. 84. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukoc Biol 1993;54:363-78.
85. 85. Kawahito K, Kawakami M, Fujiwara T, Adachi H, Ino T. Interleukin-8 and monocyte chemotactic activating factor responses to cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;110:99-102.
86. 86. Boyle EM Jr, Pohlman TH, Cornejo CJ, Verrier ED. Ischemia-reperfusion injury. Ann Thorac Surg 1997;64:S24-30.
87. 87. Filep JG, Delalandre A, Payette Y, Foldes-Filep Eva. Glucocorticoid receptor regulates expression of L-selectin and CD11/ CD18 on human neutrophils. Circulation 1997;96:295-301.
88. 88. Royston D, Bidstrup BP, Taylor KM, Sapford RN. Effect of aprotinin on need for blood transfusions after repeat open heart surgery Lancet 1987;ii:1289-91.
89. 89. Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA. Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. 1996;83: 696-700.